Skip to main content

. 1981 Jan;11(1):89–91. doi: 10.1111/j.1365-2125.1981.tb01108.x

Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver.

D S Davies, G C Kahn, S Murray, M J Brodie, A R Boobis

PMCID: PMC1401705 PMID: 7213514

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bertilsson L., Dengler H. J., Eichelbaum M., Schulz H. U. Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Eur J Clin Pharmacol. 1980 Feb;17(2):153–155. doi: 10.1007/BF00562624. [DOI] [PubMed] [Google Scholar]
Boobis A. R., Brodie M. J., Davies D. S., Kahn G. C., Whyte C. Biphasic Michaelis-Menten kinetics for ethoxycoumarin and phenacetin metabolism by human and rat hepatic monooxygenases [proceedings]. Br J Pharmacol. 1979 Jul;66(3):428P–428P. [PMC free article] [PubMed] [Google Scholar]
Boobis A. R., Brodie M. J., Kahn G. C., Fletcher D. R., Saunders J. H., Davies D. S. Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens. Br J Clin Pharmacol. 1980 Jan;9(1):11–19. doi: 10.1111/j.1365-2125.1980.tb04790.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Inaba T., Otton S. V., Kalow W. Deficient metabolism of debrisoquine and sparteine. Clin Pharmacol Ther. 1980 Apr;27(4):547–549. doi: 10.1038/clpt.1980.77. [DOI] [PubMed] [Google Scholar]
Mahgoub A., Idle J. R., Dring L. G., Lancaster R., Smith R. L. Polymorphic hydroxylation of Debrisoquine in man. Lancet. 1977 Sep 17;2(8038):584–586. doi: 10.1016/s0140-6736(77)91430-1. [DOI] [PubMed] [Google Scholar]
Malcolm S. L., Marten T. R. Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometry. Anal Chem. 1976 May;48(6):807–809. doi: 10.1021/ac60370a045. [DOI] [PubMed] [Google Scholar]
Ritchie J. C., Sloan T. P., Idle J. R., Smith R. L. Toxicological implications of polymorphic drug metabolism. Ciba Found Symp. 1980;76:219–244. doi: 10.1002/9780470720592.ch12. [DOI] [PubMed] [Google Scholar]
Sloan T. P., Mahgoub A., Lancaster R., Idle J. R., Smith R. L. Polymorphism of carbon oxidation of drugs and clinical implications. Br Med J. 1978 Sep 2;2(6138):655–657. doi: 10.1136/bmj.2.6138.655. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tucker G. T., Silas J. H., Iyun A. O., Lennard M. S., Smith A. J. Polymorphic hydroxylation of debrisoquine. Lancet. 1977 Oct 1;2(8040):718–718. doi: 10.1016/s0140-6736(77)90527-x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES